Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03096002
Other study ID # H16-02028
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 12, 2017
Est. completion date April 2019

Study information

Verified date May 2018
Source University of British Columbia
Contact Mary E Jung, Ph.D.
Phone 250 807 9670
Email mary.jung@ubc.ca
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to address whether inactive individuals with prediabetes who take part in the Small Steps for Big Changes program, which is a 3-week supervised exercise and lifestyle change program with brief counseling, will be more adherent to regular exercise one year after program completion compared to before they took part in the program.


Description:

The study is a one-group repeated measures design and the primary outcome is exercise adherence at 12 months post the 3-week supervised exercise program. There is no randomization of individuals to conditions. Exercise adherence will be measured using self-report physical activity (using the Godin leisure time exercise questionnaire) and a subsample will also wear tri-axial accelerometers to measure total time spent in moderate-to-vigorous physical activity assessed over 7 days. Secondary outcomes include physical fitness, haemoglobin A1C, quality of life, self-regulatory efficacy, anthropometrics, diet and exercise-related cognitive errors.

The 3-week lifestyle program includes six sessions with a lifestyle coach and exercise sessions performed at home. These sessions will focus on regular healthy lifestyle that includes walking (or exercise of any kind) at least three times per week and will highlight simple dietary strategies that are linked to reduced risk of T2D. The 3-week supervised exercise program includes brief exercise counseling sessions that teach participants self-regulatory skills to promote independence and long-term adherence to exercise and a healthy diet. At the conclusion of the three-week program, participants will be asked to continue exercising a minimum of three times per week for twelve months on their own.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date April 2019
Est. primary completion date April 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- ability to speak and read English

- BMI between 25-40 kg/m2 (as measured by body mass and height self-reporting),

- blood pressure of <160/99 mm Hg assessed according to CHEP guidelines,

- not diagnosed with type 2 diabetes

- no prior history of cardiovascular disease

- not on hormone replacement therapy

- Cardiovascular medications (e.g., statins) will be allowed if the participant is on stable therapy (6 months on same dose).

Exclusion Criteria, if subjects:

- take glucose-lowering medications that have changed within the past 6 months;

- report any explicit contraindications to exercise (e.g., musculoskeletal injury, chest pain during exercise)

- report having had a heart attack or stroke in the past;

- report that they are pregnant or plan on becoming pregnant over the next 12 months;

- have uncontrolled major depression;

- have bone or joint problem (for example, back, knee, or hip) that could be made worse by a change in physical activity which a physician has not cleared them for to exercise;

- report that a physician has not cleared their participant for exercise.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Lifestyle change
The 3-week lifestyle change program will introduce participants to a regular healthy lifestyle including exercise and dietary changes for reducing sugar intake, reducing refined/processed carbohydrate intake, increasing vegetable consumption. The 3-week program will include six supervised exercise sessions and three exercise sessions performed independently (e.g., at home or outside of the lab). The supervised session will include brief behavioral counseling sessions that teach participants self-regulatory skills to promote independence and long-term adherence to exercising and dietary changes.

Locations

Country Name City State
Canada YMCA of Okanagan Kelowna British Columbia

Sponsors (1)

Lead Sponsor Collaborator
University of British Columbia

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other blood pressure mean arterial blood pressure assessed manually before the program begins (week 0), after the program is completed (week 3), 24 weeks after completion of the program (week 27), and 52 weeks after completion of the program (week 55)
Other weight body weight assessed by objective scale before the program begins (week 0), after the program is completed (week 3), 24 weeks after completion of the program (week 27), and 52 weeks after completion of the program (week 55)
Other waist circumference circumference of the waist assessed manually before the program begins (week 0), after the program is completed (week 3), 24 weeks after completion of the program (week 27), and 52 weeks after completion of the program (week 55)
Other reach reach of the program as assessed by RE-AIM before the program begins (week 0)
Other dietary adherence brief food frequency questionnaire before the program begins (week 0), 24 weeks after completion of the program (week 27), and 52 weeks after completion of the program (week 55)
Primary minutes of moderate to vigorous physical activity objective measure of physical activity will be measured using tri-axial accelerometers in a subsample of ~100 participants change from before participants begin the program to 52 weeks after they finish the program for 7 consecutive days
Primary independent bouts of physical activity self-reported measure of bouts of physical activity as assessed by the Godin Leisure Time Exercise Questionnaire change from when participants begin the program to 52 weeks after they finish the program
Secondary glucose control haemoglobin A1C change from when participants begin the program to 52 weeks after they finish the program (week 55)
Secondary Aerobic fitness six-minute walk test before the program begins (week 0), after the program is completed (week 3), 24 weeks after completion of the program (week 27), and 52 weeks after completion of the program (week 55)
Secondary Perceived health-related quality-of-life SF-12 Health Survey (Ware, Kosinski, & Keller, 1995) before the program begins (week 0), 24 weeks after completion of the program (week 27), and 52 weeks after completion of the program (week 55)
Secondary Self-regulatory efficacy for physical activity and diet questionnaire before the program begins (week 0), after the program is completed (week 3), 4-weeks after the completion of the program (week 7), 24 weeks after completion of the program (week 27), and 52 weeks after completion of the program (week 55)
Secondary minutes of moderate to vigorous physical activity objective measure of physical activity will be measured using tri-axial accelerometers in a subsample of ~100 participants 24 weeks after program completion (week 27) for 7 consecutive days
Secondary independent bouts of physical activity self-reported measure of bouts of physical activity as assessed by the Godin Leisure Time Exercise Questionnaire 4- (week 7) and 24-weeks (week 27) after completion of the program
See also
  Status Clinical Trial Phase
Recruiting NCT05354245 - Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL) N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT06115265 - Ketogenic Diet and Diabetes Demonstration Project N/A
Completed NCT03188263 - Morning Light Treatment to Improve Glucose Metabolism N/A
Recruiting NCT03821961 - 18F-FDOPA PET/CT Imaging in Patients Undergoing Metabolic Surgery N/A
Completed NCT04303468 - Intervention With a GABA Supplement in Prediabetics N/A
Recruiting NCT06094231 - Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study N/A
Completed NCT03675360 - Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial N/A
Completed NCT01910051 - Explorative Assessment of Biomarkers in Overweight and Obese Subjects
Completed NCT03527368 - The Time-Restricted Intake of Meals Study N/A
Not yet recruiting NCT06453278 - (DDS) in India: a Screening Tool to Identify Prediabetes and Undiagnosed Type 2 Diabetes in Dental Settings
Suspended NCT03240978 - Exercise Intervention for the Prevention of Prediabetes in Overweight Chinese N/A
Completed NCT02899390 - Diabetes Prevention Program in Adults of the Yaqui Tribe of Hermosillo, Sonora at Risk of Diabetes N/A
Completed NCT03865342 - Prevention of Diabetes Using Mobile-enabled, Virtual Delivery of the National Diabetes Prevention Program N/A
Recruiting NCT01972113 - Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study) N/A
Completed NCT01432509 - Prospective Follow-up of a Cohort of Pre-diabetics in the North of France (DiabeNord) N/A
Completed NCT01436916 - Oral Cholecalciferol in Prevention of Type 2 Diabetes Mellitus Phase 4
Completed NCT00990184 - Study to Evaluate the Effects of Colesevelam on Insulin Sensitivity and ß-Cell Function in Subjects With Impaired Fasting Glucose (Prediabetes) Phase 3
Completed NCT00886340 - A Lifestyle Change Program to Prevent Type 2 Diabetes Phase 2